Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kura Oncology (KURA)
NASDAQ:KURA
Kura Oncology (KURA) Stock Price & Analysis
364 Followers
KURA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$8.34 - $17.27
Previous Close$8.77
Volume843.55K
Average Volume (3M)563.32K
Market Cap
$651.05M
Enterprise ValueN/A
Total Cash (Recent Filing)$476.98M
Total Debt (Recent Filing)$13.04M
Price to Earnings (P/E)-4.3
Beta0.90
Next Earnings
Nov 08, 2023EPS Estimate
-$0.54Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.05
Shares Outstanding74,236,353
10 Day Avg. Volume662,961
30 Day Avg. Volume563,316
Standard Deviation0.17
R-Squared0.06
Alpha-0.00586
Financial Highlights & Ratios
Price to Book (P/B)1.40
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-6.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$28.44Price Target Upside211.84% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Kura Oncology News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
KURA FAQ
What was Kura Oncology’s price range in the past 12 months?
Kura Oncology lowest stock price was $8.34 and its highest was $17.27 in the past 12 months.
What is Kura Oncology’s market cap?
Currently, no data Available
When is Kura Oncology’s upcoming earnings report date?
Kura Oncology’s upcoming earnings report date is Nov 08, 2023 which is in 39 days.
How were Kura Oncology’s earnings last quarter?
Kura Oncology released its earnings results on Aug 03, 2023. The company reported -$0.53 earnings per share for the quarter, beating the consensus estimate of -$0.544 by $0.014.
Is Kura Oncology overvalued?
According to Wall Street analysts Kura Oncology’s price is currently Undervalued.
Does Kura Oncology pay dividends?
Kura Oncology does not currently pay dividends.
What is Kura Oncology’s EPS estimate?
Kura Oncology’s EPS estimate is -$0.54.
How many shares outstanding does Kura Oncology have?
Kura Oncology has 74,236,350 shares outstanding.
What happened to Kura Oncology’s price movement after its last earnings report?
Kura Oncology reported an EPS of -$0.53 in its last earnings report, beating expectations of -$0.544. Following the earnings report the stock price went up 4.364%.
Which hedge fund is a major shareholder of Kura Oncology?
Among the largest hedge funds holding Kura Oncology’s share is Deerfield Management Company, LP. It holds Kura Oncology’s shares valued at 34M.
---
Kura Oncology Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$28.44 (211.84% Upside)
$28.44 (211.84% Upside)
Blogger Sentiment
Bullish
KURA Sentiment 100%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Increased
By 1.3M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 1.6%
Last 30 Days ▼ 4.0%
Last 30 Days ▼ 4.0%
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-34.69%
12-Months-Change
Fundamentals
Return on Equity
-30.77%
Trailing 12-Months
Asset Growth
4.95%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Kura Oncology
Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia; KO-947 which is an ERK inhibitor for MAPK Pathway Tumors; and KO-539 which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in La Jolla, CA.
---
Top 5 ETFs holding KURA
Vanguard Total Stock Market ETF
$21.80M
Vanguard Health Care ETF
$1.92M
Schwab U.S. Broad Market ETF
$389.60K
Fidelity Nasdaq Composite Index ETF
$305.95K
Vanguard Russell 3000 ETF
$39.98K
Up to five ETFs with an Outperform Smart Score that hold KURA. The ETFs are listed according to market value of KURA within the ETF
Arvinas Holding Company
―
Bellicum Pharmaceuticals
―
Catalyst Biosciences
―
Corvus Pharmaceuticals
―
---